secwatch.observer — SEC 8-K summary
======================================

Issuer:     Indaptus Therapeutics, Inc. (INDP)
CIK:        0001857044
Form:       8-K
Filed at:   2024-03-25T23:59:59+00:00
Accession:  0001493152-24-011080
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Indaptus to present Decoy10 data at AACR showing immune activation
------------------------------------------------------------------

- CSO Michael Newman to present Decoy10 poster at AACR 2024 in San Diego on April 10.
- Data confirm mechanism of action: Decoy bacteria activate M1 macrophages, NK, dendritic, Th1 CD4, and CD8 T cells.
- Abstract published in AACR journal Cancer Research to support the findings.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1857044/000149315224011080/0001493152-24-011080-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1857044/000149315224011080/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-011080

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer